ÂÜÀòÂÒÂ×

Kimberly Scearce-Levie is a seasoned scientist and executive in the field of neuroscience, currently serving as Chief Scientific Officer at Manifold Bio since January 2025. Prior roles include Chief Development Officer at Cajal Neuroscience and various leadership positions at Denali Therapeutics, where responsibilities encompassed overseeing translational sciences and managing research teams. With a foundational experience at Genentech as an Associate Director and Senior Scientist, Scearce-Levie has led research on neurological disease models, managed outsourcing budgets, and collaborated with drug development teams. Scearce-Levie's academic credentials include a BA in Cognitive Science from Harvard University and a PhD in Neurobiology from Columbia University Vagelos College of Physicians and Surgeons.